Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies. Hutas G Curr Opin Investig Drugs. 2008 Nov; 9(11):1206-15. PMID: 18951300. Abstract CommentRecommendBookmarkWatch
